Business Development Manager

Sphaera Pharma is engaged in drug discovery and development activities. All research programs are based on translational research. Sphaera has established a patent portfolio that includes repurposing of drugs, a potential solution focused on cancer metastasis, methodology that allows for designing therapies using current drugs to address resistant cancers, and potential treatment for multi-drug resistant infections Since, 2009, the company claims to have filed 28 patents. The pipeline includes a portfolio of 9 products in various preclinical and clinical stages.